Vikas Goyal
InvestorPartner at Longwood Fund · Board director at Pandion Therapeutics · Board director at Spero Therapeutics
Cambridge, Massachusetts, United States
Find your path to Vikas
1,169 people in our graph share verified history with Vikas — schools, employers, funds. One of them is your warm intro.
Rebecca JamesunlockedVikas: together at The Wharton School (2008–2010)
×2Vikas: together at McKinsey & Company
×2Vikas: together at The Wharton School
×4Vikas: together at University of Pennsylvania
About
Vikas Goyal left investing to run Pandion, leading partnerships, an IPO and Merck’s $1.85B acquisition; early backer of computational drug discovery who argues experimental data, not algorithms, is AI’s bottleneck.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Board director at Pandion Therapeutics
Intro paths
→
In turn, Vikas can intro founders to Pandion Therapeutics's investors below.
Pandion Therapeutics's investors · 3
Co-founders at Pandion Therapeutics
JV
Jo VineyExecutive Officer
Board director at Spero Therapeutics
Intro paths
→
In turn, Vikas can intro founders to Spero Therapeutics's investors below.
Spero Therapeutics's investors · 7
Co-founders at Spero Therapeutics
AM
Ankit MahadeviaExecutive Officer, Director
Experience
- Longwood FundPartner, Growth Investmentscurrent2025 — presentBoston, Massachusetts, United States
- Longwood FundVenture Partner, Growth Investments2024 — 2025Boston, Massachusetts, United States
- Trekk Venture PartnersManaging Partner and Co-Founder2022 — 2024Boston, Massachusetts, United States
- Pandion therapeuticsMerck Integration2021Cambridge, Massachusetts, United States
- Pandion therapeuticsSVP Business Development2019 — 2021Cambridge, MA
- Pandion therapeuticsBoard Member2018 — 2019Cambridge, MA
- Morphic TherapeuticBoard Member2016 — 2021Waltham, MA
- Nimbus TherapeuticsBoard Member2018 — 2019Cambridge, MA
- Zikani TherapeuticsBoard Member2015 — 2019Watertown, MA
- CalciMedicaBoard Member2013 — 2019Greater San Diego Area
- SR OnePrincipal2011 — 2019
- Spero TherapeuticsBoard Member2014 — 2018Cambridge, MA
- Infinity PharmaceuticalsManager, Corporate Strategy & Development2010 — 2011
- SR OneIntern2009 — 2010
- Extera PartnersSenior Associate, Co-Founder2004 — 2008
- TiE Social EntrepreneursCo-Chair2006 — 2008
- PureTech VenturesAssociate, PureTech Development2004 — 2007
- McKinsey & CompanySenior Analyst2001 — 2003
Skills & more
Venture CapitalFinancial Modeling15Entrepreneurship22Biotechnology45Start-ups38Due Diligence54Business Development15Mergers1Strategic Planning16Corporate Development11Life Sciences8Lifesciences1
+3 more
Mergers & AcquisitionsStrategyValuationFrom Vikas's professional profile.
Investments
Board seats
Morphic TherapeuticsNimbus TherapeuticsPandionRiver Vision DevelopmentSpero Therapeutics
Investor
CalciMedicaMorphic TherapeuticPandion TherapeuticsSpero Therapeutics
Sources: the firm's website · curated public sources.
Colleagues at Longwood Fund
Al Sandrock
Strategic Advisory Board at Longwood Fund
Aleks Radovic-Moreno
Partner at Longwood Fund
Alex Margolin
Venture Partner at Longwood Fund
Annalisa D'Andrea
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund
Arielle Jackson
Head, Corporate Communications & Industry Engagement at Longwood Fund
Network1
Investors connected to Vikas in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Vikas Goyal?
- Vikas Goyal left investing to run Pandion, leading partnerships, an IPO and Merck’s $1.85B acquisition; early backer of computational drug discovery who argues experimental data, not algorithms, is AI’s bottleneck.
- Where does Vikas Goyal work?
- Vikas Goyal is Partner at Longwood Fund and Board director at Pandion Therapeutics and Board director at Spero Therapeutics.
- What does Vikas Goyal invest in?
- Vikas Goyal invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- What boards does Vikas Goyal sit on?
- Vikas Goyal holds tracked board seats at Morphic Therapeutics, Nimbus Therapeutics, Pandion, River Vision Development, Spero Therapeutics.
- What companies has Vikas Goyal invested in?
- Investments tracked here include CalciMedica, Morphic Therapeutic, Pandion Therapeutics, Spero Therapeutics.
- Where did Vikas Goyal go to school?
- Vikas Goyal studied at The Wharton School (MBA, Business); University of Pennsylvania (MBA, Health Care Management); Harvard University (BA, Neurobiology).
Same school
Also attended The Wharton School2,000
Sarah GuoFounder & General Partner of ConvictionJosh KopelmanFounder and Partner at First Round CapitalAydin SenkutFounder & Managing Partner at FelicisJack AbrahamFounder, CEO & Managing Partner of AtomicKatie RiesterPartner, Head of Investor Relations at Felicis VenturesTrevor OelschigInvestment Team at General Catalyst
+ 1,994 more
Also attended University of Pennsylvania1,419
Brian ActonCo-founder of WhatsApp; co-founder of Signal FoundationKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalDasha MaggioPartner at Felicis Ventures, writer on venture capital and founder psychologyNancy WangInvestor at Felicis VenturesLeah von SiemensPartner at Manta Ray VenturesEghosa OmoiguiFounder and Managing General Partner at EchoVC Partners
+ 1,413 more
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Shared employers
Also worked at Morphic Therapeutic4
Also worked at Nimbus Therapeutics10
Erin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsAlex Badamchi-ZadehVice President at SV Health InvestorsRosana KapellerInvestor at GV (Google Ventures)
+ 4 more
Also worked at SR One32
Freya Svedberg-KeatingInvestor at MedicxiJake BauerVenture Partner at ARCH Venture PartnersAleks Radovic-MorenoPartner at Longwood FundSimeon J. GeorgeFounder & CEO at SR One Capital ManagementRajeev DadooCOO & Managing Partner at SR One Capital ManagementJake NunnPartner at SR One Capital Management
+ 26 more
Also worked at Infinity Pharmaceuticals11
Paul MeloneInvestor at Third Rock VenturesJeffrey TongPartner at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesAndrew PalmerCo-Founder of Tamr at Underscore VCDavid GrayzelPartner at Atlas VenturePhillip SamayoaPrincipal at Atlas Venture
+ 5 more